Tonix Pharmaceuticals Holding Corp. (TNXP)
13.75
-1.25
(-8.33%)
USD |
NASDAQ |
Mar 26, 16:00
13.53
-0.22
(-1.60%)
Pre-Market: 08:44
Tonix Pharmaceuticals Cash from Investing (Quarterly) : -1.019M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 0.00 |
| Jaguar Health, Inc. | -0.054M |
| MetaVia, Inc. | 0.00 |
| Seastar Medical Holding Corp. | 0.00 |
| Jupiter Neurosciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.49M |
| Cash from Financing (Quarterly) | 59.61M |
| Free Cash Flow | -107.25M |
| Free Cash Flow Per Share (Quarterly) | -3.595 |
| Free Cash Flow to Equity (Quarterly) | -43.30M |
| Free Cash Flow to Firm (Quarterly) | -42.42M |
| Free Cash Flow Yield | -91.83% |